{"id":5571,"date":"2023-12-04T05:44:28","date_gmt":"2023-12-04T11:44:28","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5571"},"modified":"2025-06-27T11:27:04","modified_gmt":"2025-06-27T16:27:04","slug":"glenn-sblendorio-as-chairman-of-the-board","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ar\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/","title":{"rendered":"\u0634\u0631\u0643\u0629 Nanscope Therapeutics \u062a\u0648\u0627\u0635\u0644 \u0646\u0645\u0648\u0647\u0627 \u0627\u0644\u0642\u064a\u0627\u062f\u064a\u061b \u064a\u0631\u062d\u0628 \u0628\u0642\u0627\u0626\u062f \u0627\u0644\u062a\u0645\u0648\u064a\u0644 \u0648\u0627\u0644\u062a\u0643\u0646\u0648\u0644\u0648\u062c\u064a\u0627 \u0627\u0644\u062d\u064a\u0648\u064a\u0629 \u0627\u0644\u0645\u0646\u062c\u0632 \u062c\u0644\u064a\u0646 \u0633\u0628\u0644\u064a\u0646\u062f\u0648\u0631\u064a\u0648 \u0643\u0631\u0626\u064a\u0633 \u0644\u0645\u062c\u0644\u0633 \u0627\u0644\u0625\u062f\u0627\u0631\u0629"},"content":{"rendered":"
\n
\n

<\/h1>\n

\u062a\u064f\u0633\u0644\u0637 \u0627\u0644\u0625\u0636\u0627\u0641\u0629 \u0627\u0644\u062c\u062f\u064a\u062f\u0629 \u0627\u0644\u0636\u0648\u0621 \u0639\u0644\u0649 \u0627\u0633\u062a\u0645\u0631\u0627\u0631 \u062a\u0639\u0632\u064a\u0632 \u0627\u0644\u0645\u0633\u0627\u0631 \u0627\u0644\u0627\u0633\u062a\u0631\u0627\u062a\u064a\u062c\u064a \u0644\u0644\u0645\u0646\u0638\u0645\u0629<\/em><\/h3>\n<\/div>\n<\/div>\n
\n
\n
\n
\n

\u062f\u0627\u0644\u0627\u0633\u060c \u062a\u0643\u0633\u0627\u0633 \u2013 4 \u062f\u064a\u0633\u0645\u0628\u0631 2023 \u2013<\/strong> \u0623\u0639\u0644\u0646\u062a \u0634\u0631\u0643\u0629 Nanscope Therapeutics (Nanscope)\u060c \u0648\u0647\u064a \u0634\u0631\u0643\u0629 \u0644\u0644\u062a\u0643\u0646\u0648\u0644\u0648\u062c\u064a\u0627 \u0627\u0644\u062d\u064a\u0648\u064a\u0629 \u0641\u064a \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u062a\u0639\u0645\u0644 \u0639\u0644\u0649 \u062a\u0637\u0648\u064a\u0631 \u0639\u0644\u0627\u062c\u0627\u062a \u062c\u064a\u0646\u064a\u0629 \u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0645\u0648\u0631\u0648\u062b\u0629\u060c \u0627\u0644\u064a\u0648\u0645 \u0639\u0646 \u062a\u0639\u064a\u064a\u0646 \u062c\u0644\u064a\u0646 \u0633\u0628\u0644\u064a\u0646\u062f\u0648\u0631\u064a\u0648 \u0631\u0626\u064a\u0633\u064b\u0627 \u0644\u0645\u062c\u0644\u0633 \u0627\u0644\u0625\u062f\u0627\u0631\u0629\u060c \u0639\u0644\u0649 \u0623\u0646 \u064a\u0633\u0631\u064a \u0645\u0641\u0639\u0648\u0644\u0647 \u0639\u0644\u0649 \u0627\u0644\u0641\u0648\u0631. \u0648\u0645\u0639 \u0623\u0643\u062b\u0631 \u0645\u0646 30 \u0639\u0627\u0645\u064b\u0627 \u0645\u0646 \u0627\u0644\u062e\u0628\u0631\u0629 \u0627\u0644\u0645\u062b\u0627\u0644\u064a\u0629 \u0627\u0644\u062a\u064a \u062a\u0645\u064a\u0632\u062a \u0628\u0627\u0644\u0642\u064a\u0627\u062f\u0629 \u0627\u0644\u062a\u0646\u0641\u064a\u0630\u064a\u0629 \u0627\u0644\u0648\u0627\u0633\u0639\u0629 \u0641\u064a \u0635\u0646\u0627\u0639\u0629 \u0637\u0628 \u0627\u0644\u0639\u064a\u0648\u0646\u060c \u0633\u064a\u062f\u0639\u0645 \u0627\u0644\u0633\u064a\u062f \u0633\u0628\u0644\u064a\u0646\u062f\u0648\u0631\u064a\u0648 \u0634\u0631\u0643\u0629 Nanscope \u0641\u064a \u0627\u0644\u0648\u0635\u0648\u0644 \u0625\u0644\u0649 \u0631\u0624\u064a\u062a\u0647\u0627 \u0627\u0644\u0625\u0633\u062a\u0631\u0627\u062a\u064a\u062c\u064a\u0629.<\/p>\n

\u0648\u0645\u0646 \u062e\u0644\u0627\u0644 \u0645\u0646\u0635\u0628\u0647 \u0627\u0644\u062c\u062f\u064a\u062f \u0643\u0631\u0626\u064a\u0633 \u0644\u0645\u062c\u0644\u0633 \u0627\u0644\u0625\u062f\u0627\u0631\u0629\u060c \u0633\u064a\u0644\u0639\u0628 \u0627\u0644\u0633\u064a\u062f \u0633\u0628\u0644\u064a\u0646\u062f\u0648\u0631\u064a\u0648 \u062f\u0648\u0631\u064b\u0627 \u0645\u062d\u0648\u0631\u064a\u064b\u0627 \u0641\u064a \u0636\u0645\u0627\u0646 \u0641\u0639\u0627\u0644\u064a\u0629 \u0645\u062c\u0644\u0633 \u0627\u0644\u0625\u062f\u0627\u0631\u0629 \u0641\u064a \u062a\u0646\u0641\u064a\u0630 \u0627\u0644\u0625\u0633\u062a\u0631\u0627\u062a\u064a\u062c\u064a\u0629 \u0648\u0627\u0644\u062a\u0648\u062c\u064a\u0647 \u0627\u0644\u062a\u0646\u0638\u064a\u0645\u064a\u064a\u0646 \u0644\u0634\u0631\u0643\u0629 Nanscope. \u0633\u064a\u0633\u0627\u0639\u062f \u0641\u0647\u0645\u0647 \u0627\u0644\u0634\u0627\u0645\u0644 \u0644\u0644\u062a\u0645\u0648\u064a\u0644 \u0648\u062a\u0637\u0648\u064a\u0631 \u0627\u0644\u0623\u0639\u0645\u0627\u0644 \u0641\u064a \u062a\u0648\u062c\u064a\u0647 Nanscope \u062e\u0644\u0627\u0644 \u0645\u0647\u0645\u062a\u0647 \u0627\u0644\u0645\u062a\u0645\u062b\u0644\u0629 \u0641\u064a \u062c\u0644\u0628 \u0627\u0644\u0623\u0645\u0644 \u0641\u064a \u0628\u0635\u0631 \u0645\u062a\u062c\u062f\u062f \u0644\u0645\u0644\u0627\u064a\u064a\u0646 \u0627\u0644\u0623\u0634\u062e\u0627\u0635 \u0627\u0644\u0645\u0635\u0627\u0628\u064a\u0646 \u0628\u0623\u0645\u0631\u0627\u0636 \u062a\u0646\u0643\u0633 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u062a\u064a \u0644\u0627 \u064a\u0648\u062c\u062f \u0639\u0644\u0627\u062c \u0644\u0647\u0627 \u062d\u0627\u0644\u064a\u064b\u0627.<\/p>\n

\u0639\u0644\u0651\u0642 \u0627\u0644\u0633\u064a\u062f \u0633\u0628\u0644\u064a\u0646\u062f\u0648\u0631\u064a\u0648 \u0639\u0644\u0649 \u062a\u0639\u064a\u064a\u0646\u0647 \u0642\u0627\u0626\u0644\u0627\u064b: "\u064a\u0634\u0631\u0641\u0646\u064a \u0627\u0644\u0627\u0646\u0636\u0645\u0627\u0645 \u0625\u0644\u0649 \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u0643\u0631\u0626\u064a\u0633 \u0644\u0645\u062c\u0644\u0633 \u0627\u0644\u0625\u062f\u0627\u0631\u0629. \u0625\u0646 \u0627\u0644\u062a\u0632\u0627\u0645 \u0627\u0644\u0634\u0631\u0643\u0629 \u0628\u062a\u0637\u0648\u064a\u0631 \u0639\u0644\u0627\u062c\u0627\u062a \u0645\u0628\u062a\u0643\u0631\u0629 \u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u062a\u0646\u0643\u0633\u064a\u0629 \u064a\u062a\u0648\u0627\u0641\u0642 \u0645\u0639 \u0634\u063a\u0641\u064a \u0628\u0625\u062d\u062f\u0627\u062b \u062a\u0623\u062b\u064a\u0631 \u0645\u0644\u0645\u0648\u0633 \u0641\u064a \u0645\u062c\u0627\u0644 \u0637\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629. \u0623\u062a\u0637\u0644\u0639 \u0625\u0644\u0649 \u0627\u0644\u0639\u0645\u0644 \u0628\u062a\u0639\u0627\u0648\u0646 \u0648\u062b\u064a\u0642 \u0645\u0639 \u0645\u062c\u0644\u0633 \u0627\u0644\u0625\u062f\u0627\u0631\u0629 \u0648\u0641\u0631\u064a\u0642 \u0627\u0644\u0642\u064a\u0627\u062f\u0629 \u0644\u062f\u0641\u0639 \u0639\u062c\u0644\u0629 \u0627\u0644\u0627\u0628\u062a\u0643\u0627\u0631 \u0648\u0627\u0644\u0645\u0633\u0627\u0647\u0645\u0629 \u0641\u064a \u062a\u062d\u0642\u064a\u0642 \u0631\u0633\u0627\u0644\u062a\u0646\u0627 \u0627\u0644\u0645\u0634\u062a\u0631\u0643\u0629."\u201c<\/p>\n

\u0641\u064a \u0627\u0644\u0622\u0648\u0646\u0629 \u0627\u0644\u0623\u062e\u064a\u0631\u0629\u060c \u062a\u0648\u0644\u0649 \u0627\u0644\u0633\u064a\u062f \u0633\u0628\u0644\u064a\u0646\u062f\u0648\u0631\u064a\u0648 \u0627\u0644\u0639\u062f\u064a\u062f \u0645\u0646 \u0627\u0644\u0623\u062f\u0648\u0627\u0631 \u0627\u0644\u0642\u064a\u0627\u062f\u064a\u0629 \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629 \u0641\u064a \u0634\u0631\u0643\u0629 IVERIC bio, Inc.\u060c \u0648\u0647\u064a \u0625\u062d\u062f\u0649 \u0634\u0631\u0643\u0627\u062a Astellas (\u0627\u0644\u0645\u0639\u0631\u0648\u0641\u0629 \u0633\u0627\u0628\u0642\u064b\u0627 \u0628\u0627\u0633\u0645 Ophthotech Corporation)\u060c \u0628\u0645\u0627 \u0641\u064a \u0630\u0644\u0643 \u0627\u0644\u0631\u0626\u064a\u0633 \u0627\u0644\u062a\u0646\u0641\u064a\u0630\u064a \u0648\u0627\u0644\u0631\u0626\u064a\u0633 \u0648\u0627\u0644\u0645\u062f\u064a\u0631. \u0643\u0645\u0627 \u0634\u063a\u0644 \u0623\u064a\u0636\u064b\u0627 \u0645\u0646\u0635\u0628 \u0646\u0627\u0626\u0628 \u0627\u0644\u0631\u0626\u064a\u0633 \u0627\u0644\u062a\u0646\u0641\u064a\u0630\u064a\u060c \u0648\u0627\u0644\u0645\u062f\u064a\u0631 \u0627\u0644\u062a\u0646\u0641\u064a\u0630\u064a \u0644\u0644\u0639\u0645\u0644\u064a\u0627\u062a\u060c \u0648\u0627\u0644\u0645\u062f\u064a\u0631 \u0627\u0644\u0645\u0627\u0644\u064a\u060c \u0648\u0623\u0645\u064a\u0646 \u0627\u0644\u0635\u0646\u062f\u0648\u0642. \u0628\u0627\u0644\u0625\u0636\u0627\u0641\u0629 \u0625\u0644\u0649 \u0630\u0644\u0643\u060c \u0634\u063a\u0644 \u0645\u0646\u0635\u0628 \u0627\u0644\u0631\u0626\u064a\u0633 \u0648\u0627\u0644\u0645\u062f\u064a\u0631 \u0627\u0644\u0645\u0627\u0644\u064a \u0648\u0627\u0644\u0645\u062f\u064a\u0631 \u0641\u064a \u0634\u0631\u0643\u0629 \u0627\u0644\u0623\u062f\u0648\u064a\u0629 \u0648\u0646\u0627\u0626\u0628 \u0627\u0644\u0631\u0626\u064a\u0633 \u0627\u0644\u062a\u0646\u0641\u064a\u0630\u064a \u0648\u0627\u0644\u0645\u062f\u064a\u0631 \u0627\u0644\u0645\u0627\u0644\u064a \u0641\u064a \u0634\u0631\u0643\u0629 Eyetech Pharmaceuticals. \u0641\u064a \u0648\u0642\u062a \u0633\u0627\u0628\u0642 \u0645\u0646 \u062d\u064a\u0627\u062a\u0647 \u0627\u0644\u0645\u0647\u0646\u064a\u0629\u060c \u0643\u0627\u0646 \u0627\u0644\u0633\u064a\u062f \u0633\u0628\u0644\u064a\u0646\u062f\u0648\u0631\u064a\u0648 \u0645\u062f\u064a\u0631\u064b\u0627 \u0625\u062f\u0627\u0631\u064a\u064b\u0627 \u0644\u0634\u0631\u0643\u0629 MPM Capital Advisors, LLC\u060c \u0648\u0634\u063a\u0644 \u0627\u0644\u0639\u062f\u064a\u062f \u0645\u0646 \u0627\u0644\u0645\u0646\u0627\u0635\u0628 \u0627\u0644\u0645\u0627\u0644\u064a\u0629 \u0627\u0644\u0639\u0644\u064a\u0627 \u0641\u064a \u0634\u0631\u0643\u0629 Hoffman-La Roche.<\/p>\n

\u0623\u0639\u0631\u0628\u062a \u0633\u0648\u0644\u0627\u062c\u0646\u0627 \u0628\u0647\u0627\u062a\u0627\u0634\u0627\u0631\u064a\u0627\u060c \u0627\u0644\u0631\u0626\u064a\u0633\u0629 \u0627\u0644\u062a\u0646\u0641\u064a\u0630\u064a\u0629 \u0648\u0627\u0644\u0645\u0624\u0633\u0633\u0629 \u0627\u0644\u0645\u0634\u0627\u0631\u0643\u0629 \u0644\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628\u060c \u0639\u0646 \u062d\u0645\u0627\u0633\u0647\u0627 \u0644\u0647\u0630\u0627 \u0627\u0644\u062a\u0639\u064a\u064a\u0646\u060c \u0642\u0627\u0626\u0644\u0629\u064b: "\u064a\u0633\u0639\u062f\u0646\u0627 \u0627\u0646\u0636\u0645\u0627\u0645 \u063a\u0644\u064a\u0646 \u0633\u0628\u0644\u064a\u0646\u062f\u0648\u0631\u064a\u0648 \u0625\u0644\u0649 \u0645\u062c\u0644\u0633 \u0625\u062f\u0627\u0631\u062a\u0646\u0627. \u0625\u0646 \u062e\u0628\u0631\u062a\u0647 \u0627\u0644\u0648\u0627\u0633\u0639\u0629 \u0641\u064a \u0628\u0646\u0627\u0621 \u0648\u062a\u0637\u0648\u064a\u0631 \u0627\u0644\u0634\u0631\u0643\u0627\u062a \u0627\u0644\u0631\u0627\u0626\u062f\u0629\u060c \u0625\u0644\u0649 \u062c\u0627\u0646\u0628 \u0645\u0639\u0631\u0641\u062a\u0647 \u0627\u0644\u0639\u0645\u064a\u0642\u0629 \u0628\u0646\u062c\u0627\u062d \u0637\u0631\u062d \u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0641\u064a \u0627\u0644\u0633\u0648\u0642\u060c \u0633\u062a\u0639\u0632\u0632 \u0628\u0644\u0627 \u0634\u0643 \u0645\u0643\u0627\u0646\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u0643\u0634\u0631\u0643\u0629 \u0631\u0627\u0626\u062f\u0629 \u0641\u064a \u0645\u062c\u0627\u0644 \u0637\u0628 \u0627\u0644\u0639\u064a\u0648\u0646. \u0648\u0646\u062a\u0637\u0644\u0639 \u0625\u0644\u0649 \u0627\u0644\u0627\u0633\u062a\u0641\u0627\u062f\u0629 \u0645\u0646 \u062e\u0628\u0631\u062a\u0647 \u0641\u064a \u0627\u0644\u0645\u0631\u0627\u062d\u0644 \u0627\u0644\u0642\u0627\u062f\u0645\u0629 \u0645\u0646 \u0645\u0633\u064a\u0631\u062a\u0646\u0627 \u0627\u0644\u062a\u0637\u0648\u064a\u0631\u064a\u0629."\u201c<\/p>\n

\u064a\u0646\u0636\u0645 \u0627\u0644\u0633\u064a\u062f \u0633\u0628\u0644\u064a\u0646\u062f\u0648\u0631\u064a\u0648 \u0625\u0644\u0649 \u0627\u0644\u0634\u0631\u0643\u0629 \u0641\u064a \u0648\u0642\u062a \u062d\u0627\u0633\u0645\u060c \u0648\u064a\u0639\u0643\u0633 \u062a\u0639\u064a\u064a\u0646\u0647 \u0627\u0644\u062a\u0632\u0627\u0645 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u0628\u062a\u0639\u0632\u064a\u0632 \u0623\u062b\u0631 \u0645\u062c\u0644\u0633 \u0627\u0644\u0625\u062f\u0627\u0631\u0629 \u0645\u0646 \u062e\u0644\u0627\u0644 \u062a\u0634\u0643\u064a\u0644 \u0641\u0631\u064a\u0642 \u0645\u0646 \u0627\u0644\u0645\u0633\u062a\u0634\u0627\u0631\u064a\u0646 \u0627\u0644\u0645\u062a\u0645\u064a\u0632\u064a\u0646 \u0630\u0648\u064a \u0627\u0644\u062e\u0628\u0631\u0627\u062a \u0627\u0644\u0645\u062a\u0646\u0648\u0639\u0629 \u0644\u062f\u0641\u0639 \u0639\u062c\u0644\u0629 \u0627\u0644\u0627\u0628\u062a\u0643\u0627\u0631 \u0648\u0627\u0644\u0646\u062c\u0627\u062d \u0641\u064a \u0627\u0644\u0634\u0631\u0643\u0629. \u062a\u064f\u0643\u0631\u0651\u0633 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062c\u0647\u0648\u062f\u0647\u0627 \u0644\u0627\u0628\u062a\u0643\u0627\u0631 \u062d\u0644\u0648\u0644 \u062c\u062f\u064a\u062f\u0629 \u0648\u0645\u0628\u062a\u0643\u0631\u0629 \u0644\u0639\u0644\u0627\u062c \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629\u060c \u062a\u064f\u062d\u062f\u062b \u0623\u062b\u0631\u0627\u064b \u0625\u064a\u062c\u0627\u0628\u064a\u0627\u064b \u062f\u0627\u0626\u0645\u0627\u064b \u0639\u0644\u0649 \u0627\u0644\u0645\u0631\u0636\u0649 \u0648\u0627\u0644\u0623\u0637\u0628\u0627\u0621.<\/p>\n

\u0646\u0628\u0630\u0629 \u0639\u0646 \u0627\u0644\u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628
\n<\/strong>www.nanostherapeutics.com<\/a>
\n<\/strong>\u062a\u0639\u0645\u0644 \u0634\u0631\u0643\u0629 Nanscope Therapeutics \u0639\u0644\u0649 \u062a\u0637\u0648\u064a\u0631 \u0639\u0644\u0627\u062c\u0627\u062a \u063a\u064a\u0631 \u062c\u064a\u0646\u064a\u0629 \u0648\u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0644\u0645\u0644\u0627\u064a\u064a\u0646 \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0645\u0635\u0627\u0628\u064a\u0646 \u0628\u0627\u0644\u0639\u0645\u0649 \u0628\u0633\u0628\u0628 \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0645\u0648\u0631\u0648\u062b\u0629\u060c \u0648\u0627\u0644\u062a\u064a \u0644\u0627 \u064a\u0648\u062c\u062f \u0639\u0644\u0627\u062c \u0644\u0647\u0627. \u0623\u0639\u0644\u0646\u062a \u0627\u0644\u0623\u0635\u0648\u0644 \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629 \u0644\u0644\u0634\u0631\u0643\u0629\u060c MCO-010\u060c \u0645\u0624\u062e\u0631\u064b\u0627 \u0639\u0646 \u0646\u062a\u0627\u0626\u062c \u0631\u0626\u064a\u0633\u064a\u0629 \u0645\u0646 \u062a\u062c\u0631\u0628\u0629 RESTORE Phase 2b \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u0645\u0631\u0627\u0643\u0632 \u0648\u0627\u0644\u0639\u0634\u0648\u0627\u0626\u064a\u0629 \u0648\u0645\u0632\u062f\u0648\u062c\u0629 \u0627\u0644\u0642\u0646\u0627\u0639 \u0648\u0627\u0644\u062e\u0627\u0636\u0639\u0629 \u0644\u0644\u062a\u062d\u0643\u0645 \u0627\u0644\u0648\u0647\u0645\u064a \u0641\u064a \u0627\u0644\u0648\u0644\u0627\u064a\u0627\u062a \u0627\u0644\u0645\u062a\u062d\u062f\u0629 \u0644\u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a.\u00a0(NCT04945772)<\/a>. \u0643\u0645\u0627 \u0623\u0643\u0645\u0644\u062a \u0627\u0644\u0634\u0631\u0643\u0629 \u0645\u0624\u062e\u0631\u064b\u0627 \u062a\u062c\u0631\u0628\u0629 \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062b\u0627\u0646\u064a\u0629 \u0645\u0646 \u0639\u0644\u0627\u062c STARLIGHT \u0644\u0639\u0644\u0627\u062c MCO-010 \u0644\u062f\u0649 \u0645\u0631\u0636\u0649 Stargardt\u00a0(NCT05417126)<\/a>. \u062d\u0635\u0644 MCO-010 \u0639\u0644\u0649 \u062a\u0633\u0645\u064a\u0627\u062a \u0627\u0644\u0645\u0633\u0627\u0631 \u0627\u0644\u0633\u0631\u064a\u0639 \u0645\u0646 \u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u063a\u0630\u0627\u0621 \u0648\u0627\u0644\u062f\u0648\u0627\u0621 (FDA) \u0648\u062a\u0633\u0645\u064a\u0627\u062a \u0627\u0644\u0623\u062f\u0648\u064a\u0629 \u0627\u0644\u064a\u062a\u064a\u0645\u0629 \u0645\u0646 \u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u063a\u0630\u0627\u0621 \u0648\u0627\u0644\u062f\u0648\u0627\u0621 (FDA) \u0644\u0643\u0644 \u0645\u0646 \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a \u0648Stargardt. \u062a\u0634\u0645\u0644 \u0627\u0644\u0623\u0635\u0648\u0644 \u0642\u0628\u0644 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062c\u064a\u0646\u064a \u063a\u064a\u0631 \u0627\u0644\u0641\u064a\u0631\u0648\u0633\u064a MCO-020 \u0644\u0644\u0636\u0645\u0648\u0631 \u0627\u0644\u062c\u063a\u0631\u0627\u0641\u064a.<\/p>\n

\u0644\u0644\u0627\u0633\u062a\u0641\u0633\u0627\u0631\u0627\u062a \u0627\u0644\u0625\u0639\u0644\u0627\u0645\u064a\u0629\u060c \u064a\u0631\u062c\u0649 \u0627\u0644\u0627\u062a\u0635\u0627\u0644 \u0628\u0640:<\/strong>
\n\u0634\u0631\u0643\u0627\u0621 \u0623\u0631\u063a\u0648\u062a
\n212-600-1902
\nPR@nanostherapeutics.com<\/a><\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"

New Addition Highlights Continued Enhancement of Organization\u2019s Strategic Trajector Dallas, TX \u2013 December 4, 2023 \u2013 Nanoscope Therapeutics (Nanoscope), a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, today announced the appointment of Glenn Sblendorio as Chairman of the Board, effective immediately. With more than 30 years of exemplary experience marked by extensive […]<\/p>\n","protected":false},"author":6,"featured_media":5573,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5571","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ar\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ar\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-04T11:44:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T16:27:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 \u062f\u0642\u0627\u0626\u0642\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board\",\"datePublished\":\"2023-12-04T11:44:28+00:00\",\"dateModified\":\"2025-06-27T16:27:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/\"},\"wordCount\":547,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/NSCOPE_LI_Sblendorio1.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ar\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/\",\"name\":\"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/NSCOPE_LI_Sblendorio1.jpg\",\"datePublished\":\"2023-12-04T11:44:28+00:00\",\"dateModified\":\"2025-06-27T16:27:04+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/NSCOPE_LI_Sblendorio1.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/NSCOPE_LI_Sblendorio1.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633 \u062a\u0648\u0627\u0635\u0644 \u0646\u0645\u0648 \u0642\u064a\u0627\u062f\u062a\u0647\u0627\u061b \u0648\u062a\u0631\u062d\u0628 \u0628\u0627\u0646\u0636\u0645\u0627\u0645 \u063a\u0644\u064a\u0646 \u0633\u0628\u0644\u064a\u0646\u062f\u0648\u0631\u064a\u0648\u060c \u0627\u0644\u062e\u0628\u064a\u0631 \u0627\u0644\u0645\u0627\u0644\u064a \u0648\u0627\u0644\u062a\u0642\u0646\u064a \u0627\u0644\u062d\u064a\u0648\u064a \u0627\u0644\u0628\u0627\u0631\u0632\u060c \u0643\u0631\u0626\u064a\u0633 \u0644\u0645\u062c\u0644\u0633 \u0627\u0644\u0625\u062f\u0627\u0631\u0629 - \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633","description":"\u062a\u064f\u0639\u062f\u0651 \u0645\u0646\u0635\u0629 \u0627\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u062e\u0635\u0627\u0626\u0635 (MCO) \u0627\u0644\u062e\u0627\u0635\u0629 \u0628\u0646\u0627 \u0627\u0644\u0623\u0648\u0644\u0649 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0627\u0644\u062a\u064a \u0623\u062b\u0628\u062a\u062a \u0642\u062f\u0631\u062a\u0647\u0627 \u0639\u0644\u0649 \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0644\u0645\u0631\u0636\u0649 \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0634\u062f\u064a\u062f \u0644\u0644\u0628\u0635\u0631 \u0641\u064a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629. \u0648\u0642\u062f \u0637\u0648\u0651\u0631\u062a \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062a\u0642\u0646\u064a\u0629 MCO-010\u060c \u0648\u0647\u064a \u0627\u0644\u062a\u0642\u0646\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 \u0648\u0627\u0644\u0648\u062d\u064a\u062f\u0629 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0641\u064a \u0645\u062c\u0627\u0644 \u0639\u0644\u0645 \u0627\u0644\u0628\u0635\u0631\u064a\u0627\u062a \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629\u060c \u0648\u0627\u0644\u062a\u064a \u062a\u062a\u0645\u064a\u0632 \u0628\u0646\u0637\u0627\u0642\u0647\u0627 \u0627\u0644\u0648\u0627\u0633\u0639 \u0648\u0627\u0633\u062a\u062c\u0627\u0628\u062a\u0647\u0627 \u0627\u0644\u0633\u0631\u064a\u0639\u0629 \u0648\u062d\u0633\u0627\u0633\u064a\u062a\u0647\u0627 \u0627\u0644\u0641\u0627\u0626\u0642\u0629\u060c \u0648\u0647\u064a \u062a\u0642\u0646\u064a\u0629 \u0645\u0633\u062a\u0642\u0644\u0629 \u0639\u0646 \u0627\u0644\u062c\u064a\u0646\u0627\u062a \u0627\u0644\u0645\u0633\u062a\u062e\u062f\u0645\u0629 \u0641\u064a \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ar\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/","og_locale":"ar_AR","og_type":"article","og_title":"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ar\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2023-12-04T11:44:28+00:00","article_modified_time":"2025-06-27T16:27:04+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629":"Nanoscope Therapeutics","\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"3 \u062f\u0642\u0627\u0626\u0642"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board","datePublished":"2023-12-04T11:44:28+00:00","dateModified":"2025-06-27T16:27:04+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/"},"wordCount":547,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ar"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/","url":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/","name":"\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633 \u062a\u0648\u0627\u0635\u0644 \u0646\u0645\u0648 \u0642\u064a\u0627\u062f\u062a\u0647\u0627\u061b \u0648\u062a\u0631\u062d\u0628 \u0628\u0627\u0646\u0636\u0645\u0627\u0645 \u063a\u0644\u064a\u0646 \u0633\u0628\u0644\u064a\u0646\u062f\u0648\u0631\u064a\u0648\u060c \u0627\u0644\u062e\u0628\u064a\u0631 \u0627\u0644\u0645\u0627\u0644\u064a \u0648\u0627\u0644\u062a\u0642\u0646\u064a \u0627\u0644\u062d\u064a\u0648\u064a \u0627\u0644\u0628\u0627\u0631\u0632\u060c \u0643\u0631\u0626\u064a\u0633 \u0644\u0645\u062c\u0644\u0633 \u0627\u0644\u0625\u062f\u0627\u0631\u0629 - \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg","datePublished":"2023-12-04T11:44:28+00:00","dateModified":"2025-06-27T16:27:04+00:00","description":"\u062a\u064f\u0639\u062f\u0651 \u0645\u0646\u0635\u0629 \u0627\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u062e\u0635\u0627\u0626\u0635 (MCO) \u0627\u0644\u062e\u0627\u0635\u0629 \u0628\u0646\u0627 \u0627\u0644\u0623\u0648\u0644\u0649 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0627\u0644\u062a\u064a \u0623\u062b\u0628\u062a\u062a \u0642\u062f\u0631\u062a\u0647\u0627 \u0639\u0644\u0649 \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0644\u0645\u0631\u0636\u0649 \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0634\u062f\u064a\u062f \u0644\u0644\u0628\u0635\u0631 \u0641\u064a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629. \u0648\u0642\u062f \u0637\u0648\u0651\u0631\u062a \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062a\u0642\u0646\u064a\u0629 MCO-010\u060c \u0648\u0647\u064a \u0627\u0644\u062a\u0642\u0646\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 \u0648\u0627\u0644\u0648\u062d\u064a\u062f\u0629 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0641\u064a \u0645\u062c\u0627\u0644 \u0639\u0644\u0645 \u0627\u0644\u0628\u0635\u0631\u064a\u0627\u062a \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629\u060c \u0648\u0627\u0644\u062a\u064a \u062a\u062a\u0645\u064a\u0632 \u0628\u0646\u0637\u0627\u0642\u0647\u0627 \u0627\u0644\u0648\u0627\u0633\u0639 \u0648\u0627\u0633\u062a\u062c\u0627\u0628\u062a\u0647\u0627 \u0627\u0644\u0633\u0631\u064a\u0639\u0629 \u0648\u062d\u0633\u0627\u0633\u064a\u062a\u0647\u0627 \u0627\u0644\u0641\u0627\u0626\u0642\u0629\u060c \u0648\u0647\u064a \u062a\u0642\u0646\u064a\u0629 \u0645\u0633\u062a\u0642\u0644\u0629 \u0639\u0646 \u0627\u0644\u062c\u064a\u0646\u0627\u062a \u0627\u0644\u0645\u0633\u062a\u062e\u062f\u0645\u0629 \u0641\u064a \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/"]}]},{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628","description":"\u0625\u0639\u0627\u062f\u0629 \u0646\u0648\u0631 \u0627\u0644\u0623\u0645\u0644","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts\/5571","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/comments?post=5571"}],"version-history":[{"count":2,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts\/5571\/revisions"}],"predecessor-version":[{"id":9060,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts\/5571\/revisions\/9060"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/media\/5573"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/media?parent=5571"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/categories?post=5571"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/tags?post=5571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}